U.S. firm Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research.
If it seems that your news feed has been flooded with nerve-wracking updates on the COVID-19 outbreaks, have no fear—there are also plenty of positive updates on the pandemic as well.
U.S biophysicists have used the IBM-built supercomputer SUMMIT to sift through thousands of molecules and find potential compounds that could be used as a new drug against the coronavirus responsible for the current COVID-19 pandemic.